Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Ofloxacin Therapy for Ocular Infections

Introduction to Ofloxacin Therapy

  • The American Academy of Ophthalmology recommends topical antibiotics, such as ofloxacin, to prevent acute bacterial keratitis in patients with corneal abrasion, particularly following trauma or in contact lens wearers 1, 2

Ofloxacin for Corneal Abrasion

  • Prophylactic topical antibiotics, like ofloxacin, following corneal abrasion have been shown to prevent ulceration when treatment is started within 24 hours of the abrasion 1, 4
  • A broad-spectrum topical antibiotic like ofloxacin is specifically recommended for any patient presenting with corneal abrasion following trauma, as this strategy helps prevent both bacterial and fungal infections 2, 3

Efficacy Considerations

  • Single-drug therapy using fluoroquinolones like ofloxacin has been shown to be as effective as combination therapy utilizing fortified antibiotics for bacterial keratitis 5, 6

Important Caveats and Considerations

  • For contact lens-associated corneal abrasions, patching the eye or using a therapeutic contact lens is not advised due to increased risk of secondary bacterial keratitis 1, 2
  • Some pathogens have variable susceptibility to fluoroquinolones, and resistance to fluoroquinolones appears to be increasing 5, 6
  • Risk factors for fluoroquinolone resistance include recent fluoroquinolone use, hospitalization, advanced age, and recent ocular surgery 5, 7
  • For severe or central corneal infections, more aggressive dosing may be required, such as loading doses every 5-15 minutes followed by hourly applications 5, 6
  • While ofloxacin is effective for both conditions, newer generation fluoroquinolones like gatifloxacin and moxifloxacin may offer better coverage of gram-positive pathogens in some cases, though they are not FDA-approved specifically for bacterial keratitis 5, 6